Peritoneal equilibration test using a radiopharmaceutical: diethylenetriaminepentaacetate.

Area of Science:

• Nephrology and Urology
• Nuclear Medicine
• Biomedical Engineering

Background:

• Peritoneal membrane characteristics are crucial for tailoring peritoneal dialysis (PD) prescriptions and influencing patient outcomes.
• The standard Peritoneal Equilibration Test (PET) is widely used but can be complex.
• A need exists for simpler, more definitive methods to assess peritoneal membrane function.

Purpose of the Study:

• To evaluate the utility of a radiopharmaceutical, (99)Tc-diethylenetriaminepentaacetate ((99)Tc-DTPA), as a simpler alternative for assessing peritoneal membrane characteristics.
• To compare the results of this nuclear PET method with the standard PET.

Main Methods:

• Intravenous injection of (99)Tc-DTPA (370 MBq) into 20 patients undergoing PD.
• Dialysate collection after a 4-hour dwell time to measure (99)Tc-DTPA excretion.
• Categorization of patients into transporter groups (high, high-average, low-average, low) based on radiopharmaceutical excretion.
• Comparison with standard PET data from 75 patients.

Main Results:

• (99)Tc-DTPA excretion varied from 8% to 17%, enabling categorization into four transporter groups.
• Nuclear PET results showed 40% high transporters, 35% high-average, 15% low-average, and 10% low transporters in 20 patients.
• A good correlation (r=0.64, p=0.002) was observed between the nuclear PET and standard PET findings.

Conclusions:

• Nuclear PET using (99)Tc-DTPA is a reproducible method for assessing peritoneal membrane characteristics.
• This technique offers potential advantages in simplicity compared to standard PET.
• It may allow for simultaneous measurement of total clearance (PD and renal) in a single session.